Immune therapy with genetically modified tumor cells

[11] IDENTIFICATION OF A PEPTIDE RECOGNIZED BY 5 MELANOMA-SPECIFIC HUMAN CYTOTOXIC T-CELL LINES [J]. SCIENCE, 1994, 264 (5159) : 716 - 719

[12] VACCINATION WITH IRRADIATED TUMOR-CELLS ENGINEERED TO SECRETE MURINE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR STIMULATES POTENT, SPECIFIC, AND LONG-LASTING ANTITUMOR IMMUNITY [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) : 3539 - 3543

[13] EBERT T, 1990, CANCER RES, V50, P5531

[14] INTERLEUKIN-2 PRODUCTION BY TUMOR-CELLS BYPASSES T-HELPER FUNCTION IN THE GENERATION OF AN ANTITUMOR RESPONSE [J]. CELL, 1990, 60 (03) : 397 - 403

[15] FERRANDINI L, 1992, J CLIN INVEST, V91, P1183

[16] SELECTIVE INDUCTION OF B7/BB-1 ON INTERFERON-GAMMA STIMULATED MONOCYTES - A POTENTIAL MECHANISM FOR AMPLIFICATION OF T-CELL ACTIVATION THROUGH THE CD28 PATHWAY [J]. CELLULAR IMMUNOLOGY, 1991, 137 (02) : 429 - 437

[17] A PILOT-STUDY OF IMMUNIZATION WITH HLA-A2 MATCHED ALLOGENEIC MELANOMA-CELLS THAT SECRETE INTERLEUKIN-2 IN PATIENTS WITH METASTATIC MELANOMA [J]. HUMAN GENE THERAPY, 1992, 3 (06) : 677 - 690

[18] GANSBACHER B, 1990, CANCER RES, V50, P7820

[19] A PILOT-STUDY OF IMMUNIZATION WITH INTERLEUKIN-2 SECRETING ALLOGENEIC HLA-A2 MATCHED RENAL-CELL CARCINOMA-CELLS IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA [J]. HUMAN GENE THERAPY, 1992, 3 (06) : 691 - 703

[20] INTERLEUKIN-2 GENE-TRANSFER INTO TUMOR-CELLS ABROGATES TUMORIGENICITY AND INDUCES PROTECTIVE IMMUNITY [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (04) : 1217 - 1224

[11] IDENTIFICATION OF A PEPTIDE RECOGNIZED BY 5 MELANOMA-SPECIFIC HUMAN CYTOTOXIC T-CELL LINES [J]. SCIENCE, 1994, 264 (5159) : 716 - 719

[12] VACCINATION WITH IRRADIATED TUMOR-CELLS ENGINEERED TO SECRETE MURINE GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR STIMULATES POTENT, SPECIFIC, AND LONG-LASTING ANTITUMOR IMMUNITY [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (08) : 3539 - 3543

[13] EBERT T, 1990, CANCER RES, V50, P5531

[14] INTERLEUKIN-2 PRODUCTION BY TUMOR-CELLS BYPASSES T-HELPER FUNCTION IN THE GENERATION OF AN ANTITUMOR RESPONSE [J]. CELL, 1990, 60 (03) : 397 - 403

[15] FERRANDINI L, 1992, J CLIN INVEST, V91, P1183

[16] SELECTIVE INDUCTION OF B7/BB-1 ON INTERFERON-GAMMA STIMULATED MONOCYTES - A POTENTIAL MECHANISM FOR AMPLIFICATION OF T-CELL ACTIVATION THROUGH THE CD28 PATHWAY [J]. CELLULAR IMMUNOLOGY, 1991, 137 (02) : 429 - 437

[17] A PILOT-STUDY OF IMMUNIZATION WITH HLA-A2 MATCHED ALLOGENEIC MELANOMA-CELLS THAT SECRETE INTERLEUKIN-2 IN PATIENTS WITH METASTATIC MELANOMA [J]. HUMAN GENE THERAPY, 1992, 3 (06) : 677 - 690

[18] GANSBACHER B, 1990, CANCER RES, V50, P7820

[19] A PILOT-STUDY OF IMMUNIZATION WITH INTERLEUKIN-2 SECRETING ALLOGENEIC HLA-A2 MATCHED RENAL-CELL CARCINOMA-CELLS IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA [J]. HUMAN GENE THERAPY, 1992, 3 (06) : 691 - 703

[20] INTERLEUKIN-2 GENE-TRANSFER INTO TUMOR-CELLS ABROGATES TUMORIGENICITY AND INDUCES PROTECTIVE IMMUNITY [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (04) : 1217 - 1224